Grab Sources: XXII Presentation. XXII Website.
-----
And as I mentioned above, (Nasdaq: XXII) has multiple potential catalysts to focus on right now. Check them out:
No. 1 XXII Potential Catalyst - A Float This Size Could Provide An Environment For Heightened Volatility.
According to the Yahoo Finance website, XXII has a low float.
In fact, the website reports this profile to have approximately 2.21Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility potential.
If the company provides more positive company news in the first half of 2025, could it provide a near term spark?
-----
No. 2 XXII Potential Catalyst - An Analyst $13 Target Suggest Over 1,000% Potential Upside From Current Levels.
Back in February, coverage was initiated on XXII by Emerging Growth Research.
In their report, they tagged XXII with a massive $13 analyst target.
From Tuesday's closing valuation, that target suggests over 1,000% in potential upside for XXII.
Near-term upside is extraordinary based on DCF analysis relative to hammered XXII shares. Therefore, the question is will new management be able to grow the business? We are inclined to believe, so we are bullish on XXII. We initiate with a Buy-Emerging rating with a $13.00 price target.
-----
No. 3 XXII Potential Catalyst - A New Agreement Could Act As A "Foundational Building Block" To Advance VLN In The Market.
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly Smoker Friendly Adds Both VLN and Smoker Friendly Branded VLN Reduced Nicotine Content Products to its Store Lineup
MOCKSVILLE, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), ..., today announced that it has
signed an agreement with Smoker Friendly, one of its largest customers, to launch Smoker Friendly VLN branded reduced nicotine content cig-a-rette products that will become the first VLN partner brand.
The introduction of Smoker Friendly VLN and 22nd Century VLN in Smoker Friendly outlets will be
one of the first presentations of gold and menthol SKU's that introduce the new VLN branding. The addition of Smoker Friendly branded VLN and 22nd Century Group's VLN products builds on a customer relationship of over 10 years, as does the recent addition of the Smoker Friendly Black Label style cig-a-rette. The Companies are currently obtaining state approvals for these products and
expect to begin shipping in the second quarter of 2025. Larry Firestone, Chief Executive Officer of 22nd Century, said, "
We are very excited to have Smoker Friendly adopt our first VLN partner brand and also add our newly rebranded VLN products to the Smoker Friendly product offerings in their stores. This is a foundational building block to advancing VLN in the market, and will be a staged rollout as we garner state approvals. Equally important to expanding distribution will be measuring rate of sale once VLN is on the shelf."
...
-----
No. 4 XXII Potential Catalyst - FDA Rule Cites Research Using XXII Products And Sales Activity.
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cig-a-rette That Complies with the New Standard
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
Proposed Standard Designates VLNC as a New Product Category, 22nd Century Ready to Manufacture as Needed to Quickly Expand Commercialization and Distribution
FDA Expects Proposed Product Standard Would Significantly Reduce the Morbidity and Mortality Caused by Smoking
MOCKSVILLE, N.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), ..., today heralded the publication of a proposed new To-bacco Product Standard for Nicotine Yield of Cig-a-rettes and Certain Other Combusted To-bacco Products by the U.S. Food and Drug Administration.
The new proposed standard would set a maximum nicotine content of 0.7 mg nicotine per gram of to-bacco in cig-a-rettes and certain other combusted to-bacco products and take effect in two years from final approval. 22nd Century's VLN products – the only combustible cig-a-rettes authorized by the FDA as a reduced nicotine content product – already comply with this standard and are available in more than 5,000 stores across the country.
"After 26 years of commitment to nicotine harm reduction, the FDA is now clearing the path for commercial adoption of our very important VLN reduced nicotine content to-bacco products in what could be the most game-changing public health policy of a generation," said Larry Firestone, Chief Executive Officer of 22nd Century Group.
Read the full article here.
-----
No. 5 XXII Potential Catalyst - Key Oversold Technical Indicators May Suggest Strong Reversal Potential.
At 4:00PM EST Tuesday, Barchart was reporting multiple oversold leaning technical indicators for XXII.
These technicals could be signaling a healthy reversal is approaching in the near term.
Here's the definition of a "reversal" from Investopedia:
"A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart."
Here's the technicals to pay close attention to (as of 4:00PM EST Tuesday):
9-Day Relative Strength Index: 21.01%
14-Day Relative Strength Index: 24.87%
When these numbers drop down to the 30% range and lower, they can be viewed as being in oversold territory. While in this territory, they can paint the picture of a profile that is undervalued.
14-Day Raw Stochastic: 4.11%
14-Day Williams %R: 95.89%
As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued.
Keep an eye on these technicals closely.
-----
(Nasdaq: XXII) Recap - 5 Potential Catalysts To Consider Now
No. 1 - A Float This Size Could Provide An Environment For Heightened Volatility.
No. 2 - An Analyst $13 Target Suggest Over 1,000% Potential Upside From Current Levels.
No. 3 - A New Agreement Could Act As A "Foundational Building Block" To Advance VLN In The Market.
No. 4 - FDA Rule Cites Research Using XXII Products And Sales Activity.
No. 5 - Key Oversold Technical Indicators May Suggest Strong Reversal Potential.
-----
Coverage is officially initiated on 22nd Century Group, Inc. (Nasdaq: XXII).
When updates are available, I'll have them out quickly. Talk soon.
Sincerely,
Kai Parker
StockWireNews
ليست هناك تعليقات:
إرسال تعليق